Supadelixir Inc.
Records under this name other than the patents Supadelixir Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.
Showing 1 to 2 of 2 · Back to Supadelixir Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,530,421 | Isolated polypeptides used for treatment of inflammatory diseases and inhibiting cancer metastasis Lapsed on the fee record Ended Sep 10, 2025 · From the USPTO record | Lapsed on the fee record | Ended Sep 10, 2025 | From the USPTO record |
| US 8,207,128 | Polypeptide inhibiting transmigration of leukocytes or growth and/or metastasis of cancer cells, and fusion protein thereof Lapsed on the fee record Ended Jun 26, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jun 26, 2024 | From the USPTO record |